Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma
Authors:
- 1 March 2008
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 195 (3) , 318-321
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative TherapyAnnals of Surgical Oncology, 2006
- Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancerBritish Journal of Cancer, 2005
- Utility of Tumor Markers in Determining Resectability of Pancreatic CancerArchives of Surgery, 2003
- Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreasJournal of Gastrointestinal Surgery, 2003
- Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Analysis of Histopathology and OutcomeJournal of Gastrointestinal Cancer, 2003
- Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled TrialAnnals of Surgery, 2001
- Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreasJournal of Gastrointestinal Surgery, 2001
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997
- Pancreatic CancerArchives of Surgery, 1985